The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease. (2021)
Attributed to:
The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.75752
Publication URI: https://www.repository.cam.ac.uk/handle/1810/328301
Type: Journal Article/Review